Groups Issue Joint Statement Advocating for Patient Rights in ACA Fight
Seventeen patient advocacy groups have jointly released a statement on behalf of patients with preexisting conditions who utilize services provided by the ACA.
Seventeen patient advocacy groups have jointly released a statement on behalf of patients with preexisting conditions who utilize services provided by the ACA.
The Food and Drug Administration has announced a new plan to significantly modernize the regulation and oversight of dietary supplements.
A 2016 experimental rule change in National Collegiate Athletic Association (NCAA) Division I Ivy League play has been linked to a reduction in concussions among players.
Wide variations in influenza vaccine coverage have been noted across healthcare personnel based on occupation and worksite.
Focused group education and lifestyle management for chronic headaches may be an effective, low-cost treatment mechanism.
Vitamin D deficiency is a risk factor for multiple sclerosis.
Barriers to using screening tools included lack of time and lack of insurance compensation.
Ozanimod decreased both T2 and T1 brain lesions and brain volume loss in patients with relapsing multiple sclerosis.
Researchers examined patients’ disease course and the number of clinical attacks to determine the safety and efficacy of intravenous cladribine.
CRISP will determine the suitability of clozapine and risperidone as a treatment for progressive multiple sclerosis.